ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
accruals factor · long-only model fund

Foundry dNOA Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FDNOHYPOTHETICAL MODEL
Since ’99
+106%
Expense Ratio
0.29%
placeholder
Holdings
296
cap-weighted
Inception
Nov 2019
placeholder
Full Sharpe
0.26
Ann. Return (LS)
3.5%
Ann. Volatility
13.7%
Max Drawdown
-31.5%
Test Sharpe ’19–26
0.72
Test FF5 α (ann.)
14.9%
vs Fama-French 5
Test FF5 α t-stat
2.81
significant (|t| ≥ 2)
Monthly turnover
19%
of the long leg, per rebalance
Cumulative return (LS)
106%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.54
what this fund holds
Long leg ann. return
10.6%
buyable, long-only
Long-short Sharpe
0.26
requires shorting
Bottom bucket ann. return
7.0%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

296 of 296 · 100.0% of book
TickerCompanySectorMarket capWeight
1APP
APPLOVIN CORPTechnology$142.62B
12.09%
2BNY
BANK OF NEW YORK MELLON CORPFinancial Services$107.85B
9.15%
3KDP
KEURIG DR PEPPER INCConsumer Defensive$42.05B
3.57%
4RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
3.36%
5CNC
CENTENE CORPHealthcare$32.81B
2.78%
6DXCM
DEXCOM INCHealthcare$29.58B
2.51%
7TPR
TAPESTRY INCConsumer Cyclical$28.58B
2.42%
8ECHO
ECHO GLOBAL LOGISTICS INCIndustrials$26.66B
2.26%
9CPRT
COPART INCIndustrials$25.56B
2.17%
10VRSN
VERISIGN INCTechnology$25.27B
2.14%
11MDB
MONGODB INCTechnology$25.12B
2.13%
12SYM
SYMBOTIC INCIndustrials$24.86B
2.11%
13MRNA
MODERNA INCHealthcare$24.53B
2.08%
14CPAY
CORPAY INCTechnology$23.91B
2.03%
15UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
1.93%
16FTV
FORTIVE CORPTechnology$18.83B
1.60%
17DD
DUPONT DE NEMOURS INCBasic Materials$18.49B
1.57%
18BBIO
BRIDGEBIO PHARMA INCHealthcare$15.94B
1.35%
19MEDP
MEDPACE HOLDINGS INCHealthcare$15.36B
1.30%
20CRCL
CIRCLE INTERNET GROUP INCFinancial Services$15.03B
1.27%
21U
UNITY SOFTWARE INCTechnology$12.66B
1.07%
22BMRN
BIOMARIN PHARMACEUTICAL INCHealthcare$11.52B
0.98%
23HUBS
HUBSPOT INCTechnology$11.49B
0.97%
24HL
HECLA MINING COBasic Materials$9.61B
0.82%
25PTGX
PROTAGONIST THERAPEUTICS INCHealthcare$9.06B
0.77%
26OSCR
OSCAR HEALTH INCHealthcare$8.77B
0.74%
27IBRX
IMMUNITYBIO INCHealthcare$8.04B
0.68%
28RAL
RALLIANT CORPTechnology$7.85B
0.67%
29MBLY
MOBILEYE GLOBAL INCConsumer Cyclical$7.76B
0.66%
30HR
HEALTHCARE REALTY TRUST INCReal Estate$7.39B
0.63%
31TAP
MOLSON COORS BEVERAGE COConsumer Defensive$7.28B
0.62%
32MIRM
MIRUM PHARMACEUTICALS INCHealthcare$7.25B
0.61%
33RIOT
RIOT PLATFORMS INCFinancial Services$6.91B
0.59%
34FLR
FLUOR CORPIndustrials$6.86B
0.58%
35CAG
CONAGRA BRANDS INCConsumer Defensive$6.83B
0.58%
36CROX
CROCS INCConsumer Cyclical$6.81B
0.58%
37CORZ
CORE SCIENTIFIC INCTechnology$6.66B
0.56%
38LUMN
LUMEN TECHNOLOGIES INCCommunication Services$6.47B
0.55%
39APPF
APPFOLIO INCTechnology$6.36B
0.54%
40SRRK
SCHOLAR ROCK HOLDING CORPHealthcare$6.33B
0.54%
41MIDD
MIDDLEBY CORPIndustrials$6.02B
0.51%
42RIG
TRANSOCEAN LTDEnergy$5.74B
0.49%
43ENPH
ENPHASE ENERGY INCTechnology$5.48B
0.46%
44OBDC
BLUE OWL CAPITAL CORPFinancial Services$5.45B
0.46%
45RDN
RADIAN GROUP INCFinancial Services$5.24B
0.44%
46STEP
STEPSTONE GROUP INCFinancial Services$5.20B
0.44%
47SPHR
SPHERE ENTERTAINMENT COCommunication Services$5.10B
0.43%
48DFTX
DEFINIUM THERAPEUTICS INCHealthcare$4.83B
0.41%
49LBRDA
LIBERTY BROADBAND CORPCommunication Services$4.43B
0.38%
50VKTX
VIKING THERAPEUTICS INCHealthcare$4.31B
0.37%
51ALHC
ALIGNMENT HEALTHCARE INCHealthcare$4.26B
0.36%
52GFF
GRIFFON CORPIndustrials$4.20B
0.36%
53TPC
TUTOR PERINI CORPIndustrials$4.14B
0.35%
54MARA
MARA HOLDINGS INCFinancial Services$4.08B
0.35%
55LION
LIONSGATE STUDIOS CORPCommunication Services$4.03B
0.34%
56DOCS
DOXIMITY INCHealthcare$3.94B
0.33%
57TDS
TELEPHONE & DATA SYSTEMS INCCommunication Services$3.90B
0.33%
58RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.32%
59DNLI
DENALI THERAPEUTICS INCHealthcare$3.70B
0.31%
60MSGE
MADISON SQUARE GARDEN ENTERTAINMENT CORPConsumer Cyclical$3.56B
0.30%
61AB
ALLIANCEBERNSTEIN HOLDING LPFinancial Services$3.54B
0.30%
62GEF
GREIF INCConsumer Cyclical$3.52B
0.30%
63LBTYA
LIBERTY GLOBAL LTDCommunication Services$3.52B
0.30%
64CALY
CALLAWAY GOLF COConsumer Cyclical$3.48B
0.30%
65RNG
RINGCENTRAL INCTechnology$3.46B
0.29%
66SEDG
SOLAREDGE TECHNOLOGIES INCTechnology$3.25B
0.28%
67ACHC
ACADIA HEALTHCARE COMPANY INCHealthcare$3.17B
0.27%
68FSK
FS KKR CAPITAL CORPFinancial Services$3.06B
0.26%
69AD
ARRAY DIGITAL INFRASTRUCTURE INCCommunication Services$3.02B
0.26%
70PK
PARK HOTELS & RESORTS INCReal Estate$3.00B
0.25%
71AAMI
ACADIAN ASSET MANAGEMENT INCFinancial Services$2.95B
0.25%
72DAN
DANA INCConsumer Cyclical$2.87B
0.24%
73LCID
LUCID GROUP INCConsumer Cyclical$2.87B
0.24%
74HOG
HARLEY-DAVIDSON INCConsumer Cyclical$2.80B
0.24%
75CLDX
CELLDEX THERAPEUTICS INCHealthcare$2.77B
0.24%
76VERA
VERA THERAPEUTICS INCHealthcare$2.76B
0.23%
77VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.23%
78NVTS
NAVITAS SEMICONDUCTOR CORPTechnology$2.68B
0.23%
79KOD
KODIAK SCIENCES INCHealthcare$2.67B
0.23%
80NGVT
INGEVITY CORPBasic Materials$2.66B
0.23%
81GCMG
GCM GROSVENOR INCFinancial Services$2.61B
0.22%
82PTON
PELOTON INTERACTIVE INCConsumer Cyclical$2.55B
0.22%
83IMNM
IMMUNOME INCHealthcare$2.53B
0.21%
84DRVN
DRIVEN BRANDS HOLDINGS INCConsumer Cyclical$2.51B
0.21%
85TALO
TALOS ENERGY INCEnergy$2.49B
0.21%
86BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.20%
87AGIO
AGIOS PHARMACEUTICALS INCHealthcare$2.36B
0.20%
88SLDE
SLIDE INSURANCE HOLDINGS INCFinancial Services$2.35B
0.20%
89BHVN
BIOHAVEN LTDHealthcare$2.32B
0.20%
90FLYW
FLYWIRE CORPTechnology$2.24B
0.19%
91SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.19%
92DHC
DIVERSIFIED HEALTHCARE TRUSTReal Estate$2.22B
0.19%
93AGL
AGILON HEALTH INCHealthcare$2.17B
0.18%
94GT
GOODYEAR TIRE & RUBBER COConsumer Cyclical$2.10B
0.18%
95CDNA
CAREDX INCHealthcare$2.05B
0.17%
96SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.17%
97INOD
INNODATA INCTechnology$1.99B
0.17%
98AMLX
AMYLYX PHARMACEUTICALS INCHealthcare$1.97B
0.17%
99GNL
GLOBAL NET LEASE INCReal Estate$1.96B
0.17%
100DMRA
DAMORA THERAPEUTICS INCHealthcare$1.94B
0.16%
101CPRI
CAPRI HOLDINGS LTDConsumer Cyclical$1.89B
0.16%
102SAM
BOSTON BEER CO INCConsumer Defensive$1.86B
0.16%
103MQ
MARQETA INCTechnology$1.85B
0.16%
104NVCR
NOVOCURE LTDHealthcare$1.84B
0.16%
105FUN
SIX FLAGS ENTERTAINMENT CORPORATIONConsumer Cyclical$1.79B
0.15%
106ASAN
ASANA INCTechnology$1.77B
0.15%
107ZYME
ZYMEWORKS INCHealthcare$1.77B
0.15%
108BFLY
BUTTERFLY NETWORK INCHealthcare$1.73B
0.15%
109ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.14%
110FTRE
FORTREA HOLDINGS INCHealthcare$1.68B
0.14%
111CMPS
COMPASS PATHWAYS PLCHealthcare$1.67B
0.14%
112TE
T1 ENERGY INCIndustrials$1.63B
0.14%
113VIR
VIR BIOTECHNOLOGY INCHealthcare$1.59B
0.13%
114NTLA
INTELLIA THERAPEUTICS INCHealthcare$1.59B
0.13%
115INNV
INNOVAGE HOLDING CORPHealthcare$1.56B
0.13%
116ENOV
ENOVIS CORPIndustrials$1.56B
0.13%
117CNXC
CONCENTRIX CORPTechnology$1.49B
0.13%
118PRGO
PERRIGO CO PLCHealthcare$1.48B
0.13%
119TRS
TRIMAS CORPConsumer Cyclical$1.46B
0.12%
120MLTX
MOONLAKE IMMUNOTHERAPEUTICSHealthcare$1.45B
0.12%
121ECVT
ECOVYST INCBasic Materials$1.41B
0.12%
122WBTN
WEBTOON ENTERTAINMENT INCTechnology$1.41B
0.12%
123FMC
FMC CORPBasic Materials$1.40B
0.12%
124CXM
SPRINKLR INCTechnology$1.37B
0.12%
125AMN
AMN HEALTHCARE SERVICES INCHealthcare$1.36B
0.12%
126REAL
THEREALREAL INCConsumer Cyclical$1.35B
0.11%
127BW
BABCOCK & WILCOX ENTERPRISES INCIndustrials$1.35B
0.11%
128XNCR
XENCOR INCHealthcare$1.30B
0.11%
129NSSC
NAPCO SECURITY TECHNOLOGIES INCIndustrials$1.29B
0.11%
130TWO
TWO HARBORS INVESTMENT CORPReal Estate$1.27B
0.11%
131FCEL
FUELCELL ENERGY INCIndustrials$1.25B
0.11%
132CCB
COASTAL FINANCIAL CORPFinancial Services$1.20B
0.10%
133QDEL
QUIDELORTHO CORPHealthcare$1.19B
0.10%
134MGTX
MEIRAGTX HOLDINGS PLCHealthcare$1.15B
0.10%
135EYPT
EYEPOINT INCHealthcare$1.12B
0.09%
136SVC
SERVICE PROPERTIES TRUSTReal Estate$1.11B
0.09%
137SECZ
SECURITIZE CORPTechnology$1.11B
0.09%
138PCT
PURECYCLE TECHNOLOGIES INCIndustrials$1.09B
0.09%
139CGEM
CULLINAN THERAPEUTICS INCHealthcare$1.09B
0.09%
140HBNC
HORIZON BANCORP INCFinancial Services$1.04B
0.09%
141PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.09%
142FBRX
FORTE BIOSCIENCES INCHealthcare$1.00B
0.08%
143EVC
ENTRAVISION COMMUNICATIONS CORPCommunication Services$984M
0.08%
144VOR
VOR BIOPHARMA INCHealthcare$980M
0.08%
145SMPL
SIMPLY GOOD FOODS COConsumer Defensive$980M
0.08%
146KURA
KURA ONCOLOGY INCHealthcare$964M
0.08%
147ANNX
ANNEXON INCHealthcare$950M
0.08%
148AOSL
ALPHA & OMEGA SEMICONDUCTOR LTDTechnology$936M
0.08%
149APEI
AMERICAN PUBLIC EDUCATION INCConsumer Defensive$930M
0.08%
150TBPH
THERAVANCE BIOPHARMA INCHealthcare$873M
0.07%
151REPL
REPLIMUNE GROUP INCHealthcare$859M
0.07%
152NX
QUANEX BUILDING PRODUCTS CORPBasic Materials$835M
0.07%
153CYRX
CRYOPORT INCIndustrials$832M
0.07%
154FOXF
FOX FACTORY HOLDING CORPConsumer Cyclical$798M
0.07%
155CODI
COMPASS DIVERSIFIED HOLDINGSIndustrials$777M
0.07%
156KODK
EASTMAN KODAK COIndustrials$748M
0.06%
157CLYM
CLIMB BIO INCHealthcare$727M
0.06%
158AURA
AURA BIOSCIENCES INCHealthcare$723M
0.06%
159SPRY
ARS PHARMACEUTICALS INCHealthcare$695M
0.06%
160PKE
PARK AEROSPACE CORPIndustrials$677M
0.06%
161NMFC
NEW MOUNTAIN FINANCE CORPFinancial Services$672M
0.06%
162SWBI
SMITH & WESSON BRANDS INCIndustrials$665M
0.06%
163CNNE
CANNAE HOLDINGS INCConsumer Cyclical$657M
0.06%
164HELE
HELEN OF TROY LTDConsumer Defensive$655M
0.06%
165EVH
EVOLENT HEALTH INCHealthcare$654M
0.06%
166ACHV
ACHIEVE LIFE SCIENCES INCHealthcare$644M
0.05%
167FAC
FACTORIAL ENERGY INCIndustrials$610M
0.05%
168EVAC
EQV VENTURES ACQUISITION CORP IIIndustrials$598M
0.05%
169PUBM
PUBMATIC INCTechnology$591M
0.05%
170NGNE
NEUROGENE INCHealthcare$590M
0.05%
171ALIT
ALIGHT INCTechnology$584M
0.05%
172MYGN
MYRIAD GENETICS INCHealthcare$584M
0.05%
173RYAM
RAYONIER ADVANCED MATERIALS INCBasic Materials$555M
0.05%
174KELYA
KELLY SERVICES INCIndustrials$531M
0.05%
175ARVN
ARVINAS INCHealthcare$517M
0.04%
176ADV
ADVANTAGE SOLUTIONS INCCommunication Services$508M
0.04%
177OIS
OIL STATES INTERNATIONAL INCEnergy$507M
0.04%
178PAYS
PAYSIGN INCTechnology$478M
0.04%
179GTEN
GORES HOLDINGS X INCIndustrials$472M
0.04%
180KREF
KKR REAL ESTATE FINANCE TRUST INCReal Estate$469M
0.04%
181STRZ
STARZ ENTERTAINMENT CORPCommunication Services$450M
0.04%
182NEWT
NEWTEKONE INCFinancial Services$439M
0.04%
183BNED
BARNES & NOBLE EDUCATION INCConsumer Cyclical$437M
0.04%
184CCRN
CROSS COUNTRY HEALTHCARE INCHealthcare$428M
0.04%
185ASPN
ASPEN AEROGELS INCBasic Materials$425M
0.04%
186BCAR
D BORAL ARC ACQUISITION I CORPIndustrials$420M
0.04%
187MCFT
MASTERCRAFT BOAT HOLDINGS INCConsumer Cyclical$407M
0.03%
188NPAC
NEW PROVIDENCE ACQUISITION CORP IIIIndustrials$399M
0.03%
189TACO
BERTO ACQUISITION CORPIndustrials$394M
0.03%
190CRNC
CERENCE INCTechnology$390M
0.03%
191RDAG
REPUBLIC DIGITAL ACQUISITION COIndustrials$388M
0.03%
192WENN
WEN ACQUISITION CORPIndustrials$387M
0.03%
193MGPI
MGP INGREDIENTS INCConsumer Defensive$382M
0.03%
194UPB
UPSTREAM BIO INCHealthcare$382M
0.03%
195CEPT
CANTOR EQUITY PARTNERS II INCIndustrials$376M
0.03%
196ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.03%
197SDHI
SIDDHI ACQUISITION CORP (CAYMAN ISLANDS)Industrials$364M
0.03%
198CCII
COHEN CIRCLE ACQUISITION CORP IIIndustrials$360M
0.03%
199TACH
TITAN ACQUISITION CORPIndustrials$360M
0.03%
200IPCX
INFLECTION POINT ACQUISITION CORP IIIIndustrials$359M
0.03%
201KCHV
KOCHAV DEFENSE ACQUISITION CORPIndustrials$356M
0.03%
202SOUL
SOULPOWER ACQUISITION CORPIndustrials$352M
0.03%
203OYSE
OYSTER ENTERPRISES II ACQUISITION CORPIndustrials$350M
0.03%
204BLUW
BLUE WATER ACQUISITION CORP IIIIndustrials$333M
0.03%
205SEG
SEAPORT ENTERTAINMENT GROUP INCReal Estate$332M
0.03%
206XRPN
ARMADA ACQUISITION CORP IIIndustrials$330M
0.03%
207RTAC
RENATUS TACTICAL ACQUISITION CORP IIndustrials$329M
0.03%
208VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.03%
209PCAP
PROCAP ACQUISITION CORPIndustrials$326M
0.03%
210OBA
OXLEY BRIDGE ACQUISITION LTDIndustrials$325M
0.03%
211SZZL
SIZZLE ACQUISITION CORP IIIndustrials$325M
0.03%
212CRAQ
CAL REDWOOD ACQUISITION CORPIndustrials$324M
0.03%
213PMTR
PERIMETER ACQUISITION CORP IIndustrials$322M
0.03%
214TVA
TEXAS VENTURES ACQUISITION III CORPIndustrials$316M
0.03%
215LWAC
LIGHTWAVE ACQUISITION CORPIndustrials$308M
0.03%
216PSBD
PALMER SQUARE CAPITAL BDC INCFinancial Services$306M
0.03%
217FHTX
FOGHORN THERAPEUTICS INCHealthcare$305M
0.03%
218ALCO
ALICO INCConsumer Defensive$304M
0.03%
219OPTX
SYNTEC OPTICS HOLDINGS INCTechnology$302M
0.03%
220JENA
JENA ACQUISITION CORP IIIndustrials$301M
0.03%
221RAAQ
REAL ASSET ACQUISITION CORPIndustrials$300M
0.03%
222BACC
BLUE ACQUISITION CORPIndustrials$293M
0.02%
223PACH
PIONEER ACQUISITION I CORPIndustrials$293M
0.02%
224NXDT
NEXPOINT DIVERSIFIED REAL ESTATE TRUSTReal Estate$291M
0.02%
225TKNO
ALPHA TEKNOVA INCHealthcare$291M
0.02%
226JACK
JACK IN THE BOX INCConsumer Cyclical$286M
0.02%
227TVAI
THAYER VENTURES ACQUISITION CORP IIIndustrials$281M
0.02%
228AXIN
AXIOM INTELLIGENCE ACQUISITION CORP 1Industrials$280M
0.02%
229PAII
PYROPHYTE ACQUISITION CORP IIIndustrials$279M
0.02%
230CEPO
CANTOR EQUITY PARTNERS I INCIndustrials$271M
0.02%
231TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.02%
232ALMU
AELUMA INCTechnology$267M
0.02%
233SRZN
SURROZEN INCHealthcare$255M
0.02%
234VNME
VENDOME ACQUISITION CORP IIndustrials$254M
0.02%
235RILY
BRC GROUP HOLDINGS INCFinancial Services$254M
0.02%
236COPL
COPLEY ACQUISITION CORPIndustrials$248M
0.02%
237GTERA
GLOBA TERRA ACQUISITION CORPIndustrials$246M
0.02%
238RNAC
CARTESIAN THERAPEUTICS INCHealthcare$243M
0.02%
239ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.02%
240SOCA
SOLARIUS CAPITAL ACQUISITION CORPIndustrials$241M
0.02%
241MCGA
YORKVILLE ACQUISITION CORPIndustrials$241M
0.02%
242GLSI
GREENWICH LIFESCIENCES INCHealthcare$240M
0.02%
243DAAQ
DIGITAL ASSET ACQUISITION CORPIndustrials$239M
0.02%
244QUIK
QUICKLOGIC CORPTechnology$237M
0.02%
245GTE
GRAN TIERRA ENERGY INCEnergy$233M
0.02%
246SMTI
SANARA MEDTECH INCHealthcare$229M
0.02%
247ONEW
ONEWATER MARINE INCConsumer Cyclical$224M
0.02%
248CABO
CABLE ONE INCCommunication Services$223M
0.02%
249ONCH
1RT ACQUISITION CORPIndustrials$222M
0.02%
250KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.02%
251EGHA
EGH ACQUISITION CORPIndustrials$213M
0.02%
252CCAQ
COLLECTIVE ACQUISITION CORPIndustrials$212M
0.02%
253IMUX
IMMUNIC INCHealthcare$207M
0.02%
254FIGX
FIGX CAPITAL ACQUISITION CORPIndustrials$199M
0.02%
255SRI
STONERIDGE INCConsumer Cyclical$197M
0.02%
256COOK
TRAEGER INCConsumer Cyclical$193M
0.02%
257NLOP
NET LEASE OFFICE PROPERTIESReal Estate$172M
0.01%
258MRDN
MERIDIAN HOLDINGS INCCommunication Services$171M
0.01%
259NUCL
EAGLE NUCLEAR ENERGY CORPBasic Materials$166M
0.01%
260STRS
STRATUS PROPERTIES INCReal Estate$165M
0.01%
261KORE
KORE GROUP HOLDINGS INCCommunication Services$163M
0.01%
262SPEG
SILVER PEGASUS ACQUISITION CORPIndustrials$158M
0.01%
263RCEL
AVITA MEDICAL INCHealthcare$157M
0.01%
264EXOD
EXODUS MOVEMENT INCTechnology$152M
0.01%
265HOFT
HOOKER FURNISHINGS CORPConsumer Cyclical$152M
0.01%
266INAC
INDIGO ACQUISITION CORPIndustrials$152M
0.01%
267CHPT
CHARGEPOINT HOLDINGS INCConsumer Cyclical$146M
0.01%
268WHF
WHITEHORSE FINANCE INCFinancial Services$140M
0.01%
269ACNT
ASCENT INDUSTRIES COBasic Materials$138M
0.01%
270PMN
PROMIS NEUROSCIENCES INCHealthcare$136M
0.01%
271DMRC
DIGIMARC CORPTechnology$133M
0.01%
272AARD
AARDVARK THERAPEUTICS INCHealthcare$128M
0.01%
273VATE
INNOVATE CORPIndustrials$123M
0.01%
274SPRB
SPRUCE BIOSCIENCES INCHealthcare$120M
0.01%
275UFI
UNIFI INCConsumer Cyclical$118M
0.01%
276WYY
WIDEPOINT CORPTechnology$115M
0.01%
277STHO
STAR HOLDINGSReal Estate$114M
0.01%
278RVSB
RIVERVIEW BANCORP INCFinancial Services$107M
0.01%
279CHPG
CHAMPIONSGATE ACQUISITION CORPIndustrials$104M
0.01%
280CHRN
CHRONOSCALE CORPIndustrials$94M
0.01%
281LCCC
LAKESHORE ACQUISITION III CORPIndustrials$93M
0.01%
282ORIQ
ORIGIN INVESTMENT CORP IIndustrials$89M
0.01%
283GEOS
GEOSPACE TECHNOLOGIES CORPEnergy$88M
0.01%
284RLYB
RALLYBIO CORPHealthcare$87M
0.01%
285SEAT
VIVID SEATS INCCommunication Services$78M
0.01%
286ACET
ADICET BIO INCHealthcare$76M
0.01%
287CLNN
CLENE INCHealthcare$76M
0.01%
288GECC
GREAT ELM CAPITAL CORPFinancial Services$74M
0.01%
289NDLS
NOODLES & COConsumer Cyclical$66M
0.01%
290BGSF
BGSF INCIndustrials$65M
0.01%
291WFCF
WHERE FOOD COMES FROM INCTechnology$63M
0.01%
292IMA
IMAGENEBIO INCHealthcare$61M
0.01%
293SKIL
SKILLSOFT CORPConsumer Defensive$58M
0.00%
294UYSC
UY SCUTI ACQUISITION CORPIndustrials$56M
0.00%
295STEM
STEM INCTechnology$56M
0.00%
296INKT
MINK THERAPEUTICS INCHealthcare$53M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $1.18T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

10 sectors
Healthcare
28.1%
Technology
26.8%
Financial Services
14.3%
Industrials
10.7%
Consumer Cyclical
6.7%
Consumer Defensive
5.2%
Basic Materials
3.0%
Communication Services
2.8%
Real Estate
1.6%
Energy
0.8%

Portfolio Style

Size × value map of the long-leg book

296 classified
Value
Blend
Growth
Large
Mid
Small
2%4
29%13
34%16
5%29
5%23
7%35
1%41
1%14
2%58

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 87% toward Large, 70% toward Growth. +14% unclassified (63 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt87% → Large
SmallLarge
Value ↔ growth tilt70% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
3
Failed
2
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    25.3%
    Margin
    -0.3%

    Close to the line. The engine flags this verdict as one a routine data rebuild could flip. Read it as borderline rather than settled — the margin beside it is the whole story.

  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

1 verdict(s) sit within 1.0pp of their limit and can be flipped by a routine data rebuild; do not headline them, and always show the margin.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.3 (95% CI 1.0-1.4)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
12.7%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.32x
within
parametric
1.24x
within
cornish fisher
1.16x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2004
Before publication (pre-2004)
0.19
Sharpe · 3.6% p.a.
January 1999December 2004 · 72 mo
Since publication
0.30
Sharpe · 3.5% p.a.
January 2005July 2026 · 259 mo
Change in Sharpe+0.11Sharpe strengthened since publication1% of the prior annual return given up

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
58%
15 of 26 3-year windows made money
Worst window
-0.79
Sharpe, January 2009 – December 2011
January 1999July 2026
Median Sharpe
0.20
Dispersion
0.55
Best window
1.49

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.42.3%35.8%
3 yearsp.a.25.3%3.4%
5 yearsp.a.13.5%9.1%
10 yearsp.a.17.7%6.6%
Since inceptionp.a.9.0%2.6%
Calendar years
YearLong legLong-short
20267 mo29.8%25.0%
202522.7%-0.3%
202420.3%-15.8%
202335.0%10.4%
2022-28.6%22.9%
202132.7%25.6%
202038.0%7.3%
201936.5%7.4%
2018-1.4%1.7%
20175.0%-16.7%
201618.0%16.7%
2015-3.1%-2.4%
20144.9%0.5%
201338.3%6.0%
201221.3%1.2%
2011-8.7%-8.0%
201016.8%-0.6%
200938.9%-16.3%
2008-38.7%27.1%
20075.8%-8.7%
200614.7%3.1%
2005-0.1%-5.9%
20044.7%-9.9%
200351.0%10.9%
2002-36.1%-4.2%
2001-12.3%13.6%
2000-7.9%35.2%
199925.6%-24.3%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FDNO
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.29% (placeholder)
Inception2019-11-08 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$1.18T

Methodology

The Foundry dNOA Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a dNOA signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.